OSLO, Norway, Feb. 27, 2024 /PRNewswire/ — Highlights Strong operating revenues of USD 152.8 million. EBITDA was USD 93.6 million, compared to USD 127.0 million in Q4 2022. Adj. for non-recurring items, EBITDA was USD 101.5 million (Q4 2022: USD 114.3 million). Non-recurring impairment…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.